A clonality result without a complete tissue diagnosis
A veterinary biopsy contains an infiltrate of small lymphoid cells, but the section is poorly oriented and only a small part of the original lesion was sampled. A molecular assay reports a dominant antigen-receptor rearrangement pattern. The owner asks whether that single result proves a particular cancer and guarantees the same treatment response described for another animal. The submitting veterinarian has not provided the lesion distribution, prior medicines or complete clinical course. The pathologist needs to integrate the assay with morphology and appropriate immunophenotyping, assess sample quality and communicate what further information could change the interpretation. Neither the molecular peak nor a negative individual marker supplies the entire diagnosis.
1. Which conclusions need to be separated?
Read the worked answer
A dominant pattern can support clonality but does not independently establish malignancy in every specimen. Review architecture, immunophenotype, sample quality and clinical evidence.
2. How should the next decision preserve uncertainty?
Read the worked answer
Describe limitations and possible next samples or tests. Do not infer a guaranteed response or exclude disease from one negative marker without the wider evidence.